Cryoport, Inc.

Equities

CYRX

US2290503075

Air Freight & Logistics

Real-time Estimate Cboe BZX 10:08:20 08/05/2024 pm IST 5-day change 1st Jan Change
13.22 USD -19.36% Intraday chart for Cryoport, Inc. -22.23% -15.60%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Cryoport, Inc., Q1 2024 Earnings Call, May 07, 2024
Earnings Flash (CYRX) CRYOPORT Posts Q1 Revenue $54.6M, vs. Street Est of $58.8M MT
Cryoport, Inc. Reiterates Revenue Guidance for the Full Year 2024 CI
Cryoport, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
North American Morning Briefing : Stock Futures -2- DJ
B. Riley Downgrades Cryoport to Neutral From Buy, Adjusts Price Target to $19 From $22 MT
B. Riley Downgrades Cryoport to Neutral From Buy, Cuts Price Target to $19 From $22 MT
North American Morning Briefing : Investors on -2- DJ
UBS Adjusts Cryoport Price Target to $17 From $14.50, Maintains Neutral Rating MT
Tranche Update on Cryoport, Inc.'s Equity Buyback Plan announced on March 11, 2022. CI
Needham Trims Price Target on Cryoport to $18 From $19, Keeps Buy Rating MT
Transcript : Cryoport, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Cryoport Q4 Net Loss Widens, Revenue Falls; Issues Guidance MT
Earnings Flash (CYRX) CRYOPORT Posts Q4 Revenue $57.3M, vs. Street Est of $58.4M MT
Cryoport, Inc. Announces Goodwill Impairment for the Quarter Ended December 31, 2023 CI
Cryoport, Inc. Provides Revenue Guidance for the Year 2024 CI
Cryoport, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
What Alabama ruling means for patients with frozen embryos: one woman's story RE
Cryoport, Inc. Announces Transition of Edward Zecchini from the Board of Directors to Sr. Vice President - Chief Digital & Technology Officer CI
Needham Adjusts Cryoport's Price Target to $19 From $18, Maintains Buy Rating MT
UBS Ups Price Target on Cryoport to $14.50 From $13.50, Maintains Neutral Rating MT
Cryoport, Nippon Express Form Partnership to Offer Temperature-Controlled Supply Chain Services MT
Cryoport, Inc. and Nippon EXPRESS HOLDINGS, Inc. Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services CI
Cryoport Acquires Bluebird Express MT
Cryoport, Inc. acquired Bluebird Express LLC for $10.2 million. CI
Chart Cryoport, Inc.
More charts
Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
16.4 USD
Average target price
17.89 USD
Spread / Average Target
+9.08%
Consensus
  1. Stock Market
  2. Equities
  3. CYRX Stock
  4. News Cryoport, Inc.
  5. Needham Trims Price Target on Cryoport to $18 From $19, Keeps Buy Rating
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW